Logo image of ALREA.PA

REALITES (ALREA.PA) Stock Fundamental Analysis

EPA:ALREA - Euronext Paris - Matif - FR0011858190 - Common Stock - Currency: EUR

1.135  +0.02 (+2.25%)

Fundamental Rating

2

ALREA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 69 industry peers in the Real Estate Management & Development industry. ALREA may be in some trouble as it scores bad on both profitability and health. ALREA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALREA has reported negative net income.
In the past year ALREA has reported a negative cash flow from operations.
ALREA had positive earnings in each of the past 5 years.
ALREA had a negative operating cash flow in each of the past 5 years.
ALREA.PA Yearly Net Income VS EBIT VS OCF VS FCFALREA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M -60M

1.2 Ratios

ALREA's Return On Assets of -8.46% is on the low side compared to the rest of the industry. ALREA is outperformed by 76.81% of its industry peers.
The Return On Equity of ALREA (-263.66%) is worse than 86.96% of its industry peers.
Industry RankSector Rank
ROA -8.46%
ROE -263.66%
ROIC N/A
ROA(3y)0.85%
ROA(5y)1.16%
ROE(3y)6.67%
ROE(5y)8.11%
ROIC(3y)N/A
ROIC(5y)N/A
ALREA.PA Yearly ROA, ROE, ROICALREA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

In the last couple of years the Profit Margin of ALREA has declined.
ALREA's Operating Margin has declined in the last couple of years.
The Gross Margin of ALREA (6.23%) is worse than 72.46% of its industry peers.
In the last couple of years the Gross Margin of ALREA has declined.
ALREA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.23%
OM growth 3Y-9.64%
OM growth 5Y-8.44%
PM growth 3Y-39.02%
PM growth 5Y-26.59%
GM growth 3Y-21.24%
GM growth 5Y-8.32%
ALREA.PA Yearly Profit, Operating, Gross MarginsALREA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1

2. Health

2.1 Basic Checks

ALREA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALREA has less shares outstanding
The number of shares outstanding for ALREA has been increased compared to 5 years ago.
ALREA has a better debt/assets ratio than last year.
ALREA.PA Yearly Shares OutstandingALREA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALREA.PA Yearly Total Debt VS Total AssetsALREA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

ALREA has an Altman-Z score of 0.13. This is a bad value and indicates that ALREA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.13, ALREA is not doing good in the industry: 75.36% of the companies in the same industry are doing better.
A Debt/Equity ratio of 5.29 is on the high side and indicates that ALREA has dependencies on debt financing.
ALREA has a Debt to Equity ratio of 5.29. This is amonst the worse of the industry: ALREA underperforms 88.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.29
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACC4.11%
ALREA.PA Yearly LT Debt VS Equity VS FCFALREA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M

2.3 Liquidity

ALREA has a Current Ratio of 1.12. This is a normal value and indicates that ALREA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ALREA (1.12) is worse than 65.22% of its industry peers.
A Quick Ratio of 0.60 indicates that ALREA may have some problems paying its short term obligations.
ALREA has a worse Quick ratio (0.60) than 65.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.6
ALREA.PA Yearly Current Assets VS Current LiabilitesALREA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

4

3. Growth

3.1 Past

ALREA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -749.71%.
ALREA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.27% yearly.
ALREA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.96%.
The Revenue has been growing by 24.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-749.71%
EPS 3Y-27.37%
EPS 5Y-18.27%
EPS Q2Q%-2429.92%
Revenue 1Y (TTM)-14.96%
Revenue growth 3Y25.21%
Revenue growth 5Y24.65%
Sales Q2Q%-35.09%

3.2 Future

The Earnings Per Share is expected to decrease by -5.57% on average over the next years.
Based on estimates for the next years, ALREA will show a small growth in Revenue. The Revenue will grow by 4.30% on average per year.
EPS Next Y-92.63%
EPS Next 2Y-27.45%
EPS Next 3Y-5.57%
EPS Next 5YN/A
Revenue Next Year-19.74%
Revenue Next 2Y-0.24%
Revenue Next 3Y4.3%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALREA.PA Yearly Revenue VS EstimatesALREA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ALREA.PA Yearly EPS VS EstimatesALREA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

ALREA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 1.10, the valuation of ALREA can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALREA indicates a rather cheap valuation: ALREA is cheaper than 98.55% of the companies listed in the same industry.
ALREA is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 1.1
ALREA.PA Price Earnings VS Forward Price EarningsALREA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALREA.PA Per share dataALREA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A cheap valuation may be justified as ALREA's earnings are expected to decrease with -5.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.45%
EPS Next 3Y-5.57%

6

5. Dividend

5.1 Amount

ALREA has a Yearly Dividend Yield of 8.89%, which is a nice return.
ALREA's Dividend Yield is rather good when compared to the industry average which is at 7.97. ALREA pays more dividend than 86.96% of the companies in the same industry.
ALREA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.31.
Industry RankSector Rank
Dividend Yield 8.89%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALREA.PA Yearly Dividends per shareALREA.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 0.5 1 1.5

5.3 Sustainability

DP0%
EPS Next 2Y-27.45%
EPS Next 3Y-5.57%
ALREA.PA Yearly Income VS Free CF VS DividendALREA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

REALITES

EPA:ALREA (7/25/2025, 7:00:00 PM)

1.135

+0.02 (+2.25%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-25 2024-07-25
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners57.55%
Ins Owner ChangeN/A
Market Cap5.44M
Analysts86.67
Price Target17.85 (1472.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 8.89%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.1
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B 0.17
P/tB 0.22
EV/EBITDA N/A
EPS(TTM)-17.82
EYN/A
EPS(NY)1.03
Fwd EY90.75%
FCF(TTM)-11.51
FCFYN/A
OCF(TTM)-12.8
OCFYN/A
SpS70.22
BVpS6.75
TBVpS5.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.46%
ROE -263.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.23%
FCFM N/A
ROA(3y)0.85%
ROA(5y)1.16%
ROE(3y)6.67%
ROE(5y)8.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.63%
ROCE(5y)5.41%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-9.64%
OM growth 5Y-8.44%
PM growth 3Y-39.02%
PM growth 5Y-26.59%
GM growth 3Y-21.24%
GM growth 5Y-8.32%
F-Score2
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 5.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.27%
Cap/Sales 1.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.6
Altman-Z 0.13
F-Score2
WACC4.11%
ROIC/WACCN/A
Cap/Depr(3y)86.13%
Cap/Depr(5y)113.76%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-749.71%
EPS 3Y-27.37%
EPS 5Y-18.27%
EPS Q2Q%-2429.92%
EPS Next Y-92.63%
EPS Next 2Y-27.45%
EPS Next 3Y-5.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.96%
Revenue growth 3Y25.21%
Revenue growth 5Y24.65%
Sales Q2Q%-35.09%
Revenue Next Year-19.74%
Revenue Next 2Y-0.24%
Revenue Next 3Y4.3%
Revenue Next 5YN/A
EBIT growth 1Y-308.42%
EBIT growth 3Y13.14%
EBIT growth 5Y14.13%
EBIT Next Year149.51%
EBIT Next 3Y68.3%
EBIT Next 5YN/A
FCF growth 1Y0.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.11%
OCF growth 3YN/A
OCF growth 5YN/A